Clinical Trial Update: Myfortic Conversion Trial in OLT Recipients With GI Intolerance

View source ↗

Summary

Clinical trial update on converting liver transplant recipients with GI intolerance to Myfortic (mycophenolic acid).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Disorders
• Orthotopic Liver Transplantation

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: GI Disturbance | Status: COMPLETED